In this video, you were going to be learning about the top seven penny stocks for this month in June 2020. Now we make these videos about once a month and the beauty of them is that we actually have the exact date at which catalysts are going to be occurring. These are companies that give us their FDA approval dates, their face trial data release dates, and give us many hints and clues such as with insider trading activity and institutional buys. This is fantastic because if we know when the date is, we can then go and trade off it.

But to understand how to actually trade these, we're going to need to review last month's picks. In our wonderful Seven Top Penny Stocks video. from May we talked about EVs M We talked about how they were due for an FDA approval for their Vahine Agyei We announced it here. They didn't have much of a pre anticipatory run, but when it got approved, it ran from 440 to around $9 But you have to actually trade these if you buy in randomly.

Your results are going to be random. You need to buy and sell intentionally. Confirmation and validation is the abrupt, the abrupt venom. o Next we talked about Clovis Clvs was due for an FDA approval on the 15th.

We talked about how Clovis has a pattern of pre anticipatory runs to news and then sells off. Afterwards we called out Clovis at 7:14 here and then I ran up day after day up to 10.67 48 percent run to announcement. Next we talked about VX RT We talked about how VX RT. has a previous pattern of spike ability and thus we'd want to play off future spike ability.

It was actually a pretty trash play, though it did technically run up, but it was such a dirty and unclean play that this was definitely a failure. But it's very important to note that as traders, well, we don't have a crystal ball, right? So what we're doing is we're looking for Catalysts. We're tracking catalysts, and then we're going and looking at previous patterns, previous history of reacting to catalyst, and then we're going and trading off of it in the future. This is how we trade.

We don't just randomly buy and hold. Lastly, we talked about AQ Sta Qst had an upcoming approval. On May 21st, it ran from 387 to $7 which is an 80% run for you swing traders. But after the news that got beat down, this is pretty much how most of the stocks we talked about play.

They run up towards the news and then the news they could be down. And lastly, we talked about Inu I and O we about how it had a pattern of running up in anticipation and then running up massively every time it gets beat down. So ultimately we called it out here. It ran up through earnings and went from our coal out at ten dollars to about nineteen dollars before validating out and selling off.

But anyways, these picks, they're not for the faint of heart and definitely not for the dehydrated. But the point is if you don't have a plan with any of these stocks, if you're not intentional with buying these stocks and intentional with selling out, well they're going to leave you begging like a dog. Some people get really upset because they're like, well you say you called out EVF MN It went up 100 percent but I couldn't catch that because I didn't know where to sell out. But that's misleading because if you had just randomly held it, you would have lost money.

Why the heck would you have held it? We as if traders buy in at confirmation and sell out at validation. If you don't have a set entry and exit point, how are you ever going to make money? But anyways, the point is that our approach to penny stocks is fairly simple. We play the pre anticipatory run and then we play well the post run, but we don't hold through earnings and we never hold through FDA approvals because we don't know what's going to happen right? You can go either way, so stop being to think about. But anyways, folks, you know a lot of work goes into making a video like this: I Have to research all the stocks I have to do an analysis on them and I have to chase baby raccoons.

So there's a lot of work that goes into something like this. And the only thing that I ask in return is that you hit that ravishing like button. Okay and quick plug for folks who are wondering what broker to trade these stocks on. We always like to send new traders over to Ebel They are a very, very powerful platform and they are completely commissioned free and they offer some really useful tools that we need to Strader such as the ability to trade after hours in a pre market I Always see people complaining saying I wasn't able to trade in the pre-market or or I wasn't able to trade in the after hours.

but if you don't have a broker with the functionality of being able to trade during that time, how do you expect to take advantage of those moves you can't If you sign up and deposit with our link below, you will get not one but two free stocks. Pretty cool deal for people who are broker curious. Okay so to start, a lot of people think that it's rude and unprofessional to insult stocks that you were trading. But I'm just going to tell you now that a lot of these companies, well, they have faces that not even a mother could love.

Now, An Brv was originally slated to have their FDA approval decision for UTIs on April 30th, 2019. It then got delayed to June 19th, but now because of the Corona situation, it's getting delayed again. But here is the thing in the weeks running up to this original slated approval, we saw the share price pre anticipatory run from 50 cents to $1 20 cents. Now that's what we call a strong cowboy on a rodeo.

And then when they announced the delay a few weeks ago back on the 29th, it took this huge beat down here. So here's the thing, we are in a period of it d'Alene And that's why we have to beat down. But as we go through this month, if we miss that June 19th deadline and Brv will give us an update on the new date of approval and this is a great opportunity because that means that we can resume pre anticipatory runs with extra added height. Because they got delayed, right? it's built up investors speculation, it's built up volume, and now once it gets a new date, we're going to have a much better run.

We're going to have a much better opportunity and it's a better opportunity because we can get in at a better deal because if it gets beat down based on the fact that it's getting delayed, hey, the anticipatory runs going to be that much more powerful. But what are the monkey saying? Well, the monkeys are ranking it at an average price target at 2 dollars and 25 cents with most projecting approval and it doesn't really matter if it gets approved or not this month. Obviously, from a humanitarian standpoint, we want drugs that work to get approved but from a trading standpoint, it's all about making money. and this is a stock that has a lot of upside potential.

if it does end up getting approved, so we're going to need to be watching for those fluctuations and those pre anticipatory runs ok. Next CH MA Now CH Ma will be having their FDA approval decision. Further, drug probably messed up the name, but acromegaly is apparently a growth hormone disorder for those of you who are wondering. but after selling off with the overall market in March, its ran up pretty consistently and broke into new highs.

This is a stock that moved with the overall market during the beginning of the crisis and then wildly outperformed the market in the weeks and months after. That is great because we like proof and not promises. We want to show proof of price strength, but at the same time if we run up too much prior to the date, we risk losing or upside and it's already hard to say how much has already been pre factored in. But this dip from the consistent uptrend is something that I love, love-love-love and I'd love to get a good deal and take advantage of this.

next. now, Kpti will be having their FDA approval decision on June 23rd for their drug for lymphoma. Now Kpti is fun because it actually has a previous pattern of spiking massively News And this news here in early March Was actually happy to deal with the same drug that is going through approval this week. This run actually happened after Kpti announced that they had positive phase data and it ran because positive phase data is the next step towards getting an approval and having the drug enter the market.

Now that we actually have a approval decision coming, it's a whole different ballgame. I'll be looking for pre anticipatory running and I'll be looking to play the post reaction. If a positive phase data result can get us to 2961, it makes sense that an actual approval can give us similar if not more upside potential. Yes folks, not potential, but potential.

It's potent. but what? What are the monkeys saying? Well, the monkeys are giving it an average price target at $31 that 76% of monkey upside. But of course we only like the monkeys as far as we can throw them and we like to throw them far. But truthfully, the only goal with the monkey analysts is to make sure we aren't trading above their price target.

Kpti is actually owned ninety six percent by institutions aka the smart Money. We as trainers always like to think we are the smart money with our fancy charts and laptops, but the smart money is almost always these huge institutions with teams of Harvard grads that pile into the data. And that's why it's such an elevating factor when we see firms like Blackrock and Vanguard taking positions. Blackrock Specifically has a history of picking great biotech winners and it's an elevating factor whenever we see it on the ballot.

it creates more stability while also continuing our foray into insane upside. But again, these companies tend to do great running up to Catalysts. but then they tend to get B down after a catalyst. And because that sell-off after a run up is a huge possibility I need you to know that we need risk management.

One of the things that I enjoy besides taking long walks in the forest is not getting my career and handed to me as the stock gets beat down. so make a plan to sell at validation. Okay, Evoke: We'll be having their PDF a date aka FDA approval date for their female diabetic gastroparesis drug on June 19th. So they originally plotted this for April second, but this got delayed to the 19th of this month.

Now I'm not going to say that I'm a huge fan boy of EVOC because frankly, it's not true I'm not a fan boy. They are trading pretty damn high and that downward potential is insane. It makes me want to gag. but the date is on June 19th so we've got a lot of time for the price to adjust and get us a better deal.

By the way, you really know you've made it as a Youtuber when your videos get sponsored. And today I'm really proud to announce a sponsor. Water Water is very important and it actually keeps you alive. You can actually get a boat and you can float on it.

You can take a Jacuzzi in it, you can shower with it, you can spray water guns I Don't know what people do with water, but there's just so many, so many uses of water and I just want to save it. If you're not using it, well, you're a sucker. You know the Spanish they actually have a word for it agua and it's it's just it's a very spiritual thing and I think that a lot of people don't really understand the use of water and I just I wish people would think more well, righteously about it. Okay, he Pzm epgm will be having their FDA approval decision on June 18th for their drug for a lymphoma.

Anyways, this was originally approved for another type of cancer back in January of this year, but just because a drug is approved for one use doesn't mean that it's going to be approved for ever use and this month will learn if it'll be approved for lymphoma. One thing to note though is that in the weeks leading up to the previous approval, had a pre anticipatory run with some gapping up but then eventually sold off. This makes the case even stronger for playing only the pre anticipatory run. Like I've said several times, we don't like to hold through the news because we don't know what can happen.

Just because it's an FDA approval date doesn't mean that it's going to get approved. Sometimes it even gets delayed, right? so you want to make sure that you're not holding randomly through the news. But another thing to note is that since we are currently trading pretty damn low, A leading up to an approval could for sure help us to realize the much-needed upside. While monkeys are giving it an average price target at about $32 that's 83% of upside from the current trading price.

Do not trust the monkeys, but use their price targets as a way to gauge where your average sheep investor is thinking the direction is going. Let the monkeys lead to sheep, but don't be led by the monkeys nor the Sheep. Next, we have a KTX. Now a KTX has phase 3 data due on June 11th through the 14th.

This is important because back on January 10th, a KTX reported that all patients had achieved the goals of the study that resulted in a massive 75 percent run or 70 percent run back in January. But a KTX has a long history of spike ability here here here here and Heather And we love spike ability because that means that the dog has the ability the ability to react massively to news and that's something that you need to violently consider as we go into this month. Okay, and lastly, En DP now and EP will be having their FDA approval decision on July 5th for their drug for cellulite. Now, the reason that I'm mentioning this in jeans video is because even though the approval is in July, these tend to provide a lot of pre anticipatory runs up to several weeks prior to approval.

So while it's coming out in July, it's really relevant for June I like En DP because it had gotten beaten down massively in the beginning of the crisis and continued a solid downtrend. If this continues, we can get an even better deal at pre anticipatory run, but we want to make sure it actually runs, so that means we were waiting for confirmation of a reversal before buying in. What are the monkey saying? Well, monkeys are giving it a price target at 533, which is about a 33% of upside. Anyways, folks, I do hope this video is valuable for you.

If you have any questions, feel free to let us know in the comment section below or reach out to us on Zip Trader Circle. You can join Zip Trader Circle by clicking the link in the description below. It's a free Facebook group and we post nightly watch lists and answer a ton of questions on there. so it's a great community to work with other traders and meet different people with different strategies.

Also Quick sad note: I Just read that about 70% of my viewers the daily viewers that watch this channel aren't subscribed. Well, it might be because I spend so much time calling people losers if they don't have a plan or because I trade like a spoiled brat or because I spend most of my videos just yelling at my audience. But it just pains me that so many people are becoming a statistic that 70% you are not defined by that 70% You can be defined by the 30% by hitting that ravishing subscribe button. But the one thing that I do want to leave you with on this video is that these videos.

Well, they're great for pointing out opportunities. They're great for giving you some starters on strategies and starters on how to do research. but you need to go out and do your own due diligence. You don't want to depend on me or my videos to go out and make money in a stock market, right? You want to use these as a foundation to go out and make your own knowledge, build your own skill sets.

So anyways, that's just my two cents on that. Do your own due diligence. And lastly, if you are looking to learn how to trade, we are offering $50 off Stat. Trade Are you for folks who type in coupon code? Stay home 20 20 at checkout? Anyways, folks, have a great day and I'll see you in the next video.